FILICE, Rossella
 Distribuzione geografica
Continente #
EU - Europa 324
NA - Nord America 276
AS - Asia 78
Totale 678
Nazione #
US - Stati Uniti d'America 272
IE - Irlanda 97
SE - Svezia 87
IT - Italia 64
PL - Polonia 36
CN - Cina 31
SG - Singapore 30
DE - Germania 13
FR - Francia 12
IN - India 10
FI - Finlandia 5
GB - Regno Unito 5
CA - Canada 4
VN - Vietnam 4
ID - Indonesia 3
BE - Belgio 2
LT - Lituania 1
MK - Macedonia 1
UA - Ucraina 1
Totale 678
Città #
Chandler 101
Dublin 97
Nyköping 67
Warsaw 36
Messina 26
Singapore 23
Ashburn 22
Princeton 19
Medford 12
Des Moines 11
Rome 11
Bremen 10
Dearborn 8
Hyderabad 8
Beijing 5
Boardman 5
Helsinki 5
Jacksonville 5
Los Angeles 5
Santa Domenica 5
Dong Ket 4
Jinan 4
Nanjing 4
Redwood City 4
Jakarta 3
Tianjin 3
Torregrotta 3
Augusta 2
Brussels 2
Munich 2
Nanchang 2
Ottawa 2
Pozzo Di Gotto 2
Taizhou 2
Berlin 1
Changsha 1
Chengdu 1
Duncan 1
Hangzhou 1
Lanzhou 1
London 1
Maple Ridge 1
Monmouth Junction 1
Santa Teresa Di Riva 1
Seattle 1
Shenyang 1
Shenzhen 1
Toronto 1
Vittoria 1
Wuhan 1
Zhengzhou 1
Totale 537
Nome #
PRRT Retreatments: Renal Function Evaluation 91
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 82
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study 69
Dual Time-Point FET-PET/CT in Glioma Patients: a Single-Centre Preliminary Experience 66
Renal Function Evaluation in PRRT Retreatments 62
Complete response in a pancreatic NEN with liver metastasis after PRRT in association with lanreotide autogel/depot 58
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 54
Prognostic Validity of Dual Tracer PET/CT In The PRRT Enrollment of GEP-NET Patients 48
Is dual tracer PET/CT a prognostic biomarker in the PRRT enrollment of GEP-NET patients? 47
PRRT retreatments: renal function evaluation 47
The additional value of 18F-FDG PET and MRI in patients with glioma: A review of the literature from 2015 to 2020 38
Undetectable or low (< 1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients 26
null 23
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature 2
Prostate-Specific Membrane Antigen Positron Emission Tomography Oncological Applications beyond Prostate Cancer in Comparison to Other Radiopharmaceuticals 1
FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature 1
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score 1
Totale 716
Categoria #
all - tutte 3.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.261


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202038 0 0 0 0 0 6 4 3 1 6 0 18
2020/2021117 12 4 33 6 15 5 8 6 8 4 9 7
2021/2022114 1 7 1 5 13 0 1 16 0 12 7 51
2022/2023318 28 47 13 29 18 31 7 22 112 0 8 3
2023/202464 4 9 4 4 8 5 3 7 0 8 0 12
2024/202561 0 12 9 14 26 0 0 0 0 0 0 0
Totale 716